Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-22OKYO3OKYO Pharma CFO Keeren Shah's Stock Options and Common Stock Holdings
This Form 3 filing discloses the initial beneficial ownership of OKYO Pharma Ltd (OKYO) securities by Chief Financial Officer Keeren Shah. The filing reports direct ownership of 16,667 shares of common stock and extensive stock option grants. Shah holds multiple option tranches with exercise prices ranging from $1.46 t...
Micro CapBiotechnology
2026-05-22CRBP3Form 3 Filing for Corbus Pharmaceuticals Holdings, Inc.MEDIUM
This filing is an initial statement of beneficial ownership of securities filed by Nishant Saxena, Chief Business Officer of Corbus Pharmaceuticals Holdings, Inc. The filing indicates that Mr. Saxena, through his attorney-in-fact Meghan Houghton, directly owns 3,500 shares of Corbus Pharmaceuticals Holdings, Inc. commo...
Micro CapBiotechnology
2026-05-22OKYO Pharma Ltd3OKYO Pharma CFO Keeren Shah's Stock Options and Common Stock HoldingsDuplicate
This Form 3 filing discloses the initial beneficial ownership of OKYO Pharma Ltd (OKYO) securities by Chief Financial Officer Keeren Shah. The filing reports direct ownership of 16,667 shares of common stock and extensive stock option grants. Shah holds multiple option tranches with exercise prices ranging from $1.46 t...
Micro CapBiotechnology
2026-05-21ANL3Form 3 Filing - Initial Statement of Beneficial OwnershipMEDIUM
This filing is an initial statement of beneficial ownership for Adlai Nortye Ltd. (ANL). The reporting owner, LU YANG, who is the CEO, Director, and a ten percent owner, reported the ownership of 100,000 American Depositary Shares directly. Additionally, 1,6990,000 Class B ordinary shares are held indirectly through a ...
Small CapBiotechnology